Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

Peptides from Plasmodium berghei circumsporozoite protein (CS) and influenza A virus nucleoprotein (NP) were entrapped in microparticles prepared from poly (lactide-co-glycolide) polymers, and the microparticles were administered parenterally to mice. After immunization with single or multiple doses, splenocytes were tested for a cytotoxic T cell (CTL) response and high levels of CTL activity were detected. The CTL induced were CD8+, MHC class I restricted, and could recognize virus infected cells. Peptide entrapped in microparticles of mean size < 500 nm were better inducers of CTL than larger microparticles (mean > 2 microns and above). Microparticles could also be used to deliver lipid modified peptides (lipopeptides) and elicited higher levels of cytolytic activity than either free peptide in microparticles or lipopeptide alone. Microparticles provide a novel way of inducing a CTL response using synthetic peptides.

[1]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Heeg,et al.  Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. , 1994, Vaccine.

[3]  S. Galli,et al.  The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. , 1992, Journal of immunology.

[4]  D. O'hagan,et al.  Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. , 1994, Immunology.

[5]  H. V. Maulding.  Prolonged delivery of peptides by microcapsules , 1987 .

[6]  S. Davis,et al.  Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. , 1993, Vaccine.

[7]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[8]  J. Levy,et al.  Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. , 1992, Journal of immunology.

[9]  B. Rouse,et al.  Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. , 1992, Journal of immunology.

[10]  D. Nixon,et al.  Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides. , 1996, Vaccine.

[11]  R. Zinkernagel,et al.  Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide , 1990, The Journal of experimental medicine.

[12]  A. Osterhaus,et al.  Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune‐stimulating complexes , 1995, European journal of immunology.

[13]  G. E. Visscher,et al.  Tissue Response to Biodegradable Injectable Microcapsules , 1987, Journal of biomaterials applications.

[14]  A. Vitiello,et al.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.

[15]  V. Nussenzweig,et al.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.

[16]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[17]  J. Frelinger,et al.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affects CTL recognition and binding of the nucleoprotein peptide from the lymphocytic chroriomeningitis , 2004, Immunogenetics.

[18]  D. Rahman,et al.  Biodegradable microparticles for oral immunization. , 1993, Vaccine.

[19]  K. Wiesmüller,et al.  Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. , 1994, Journal of immunological methods.

[20]  M. Feltkamp,et al.  Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells , 1993, European journal of immunology.